Evaluation of Efficacy and Safety of Clevira as an Add on Drug in Mild to Moderate COVID-19 Positive Patients-A Randomised Control Trial

Authors
Category Primary study
JournalJOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH
Year 2022
This article has no abstract
Epistemonikos ID: e50691b5b5b1ecc4ab6fd918289ae9daad744e33
First added on: Feb 13, 2025